Proteomic technology in the design of new effective antibacterial vaccines

Expert Review of Proteomics

Volumn 6, Issue 3, 2009, Pages 315-330

  Jagusztyn Krynicka, Elbieta Katarzyna ^a   Dadlez, Michał ^a,b   Grabowska, Anna ^a   Roszczenko, Paula ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Antigen; Bacillus anthracis; Immunoproteomic; Proteomic; Streptococcus spp.; Subunit vaccine; Vaccinology

Indexed keywords

ANTHRAX VACCINE; BACTERIAL VACCINE; BIO THRAX; INACTIVATED VACCINE; LIVE VACCINE; OUTER MEMBRANE PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CAPILLARY ELECTROPHORESIS; ELECTROSPRAY; FRAGMENTATION REACTION; GENOMICS; HUMAN; IMMUNE RESPONSE; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; STREPTOCOCCUS; TRANSCRIPTOMICS; VACCINATION;

BACTERIA; BACTERIAL VACCINES; DRUG DESIGN; GENE EXPRESSION PROFILING; PROKARYOTIC CELLS; PROTEOMICS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); STREPTOCOCCUS;

EID: 66949152541     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.09.47     Document Type: Review

References (202)

1. Serruto D, Rappuoli R. Post-genomic vaccine development. FEBS Lett. 580(12), 2985-2992 (2006). (Pubitemid 43729171)
2. Medini D, Donati C, Tettelin H, Masignani V, Rappuoli R. The microbial pan-genome. Curr. Opin. Genet. Dev. 15(6), 589-594 (2005). (Pubitemid 41532330)
3. Mora M, Donati C, Medini D, Covacci A, Rappuoli R. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr. Opin. Microbiol. 9(5), 532-536 (2006). (Pubitemid 44397631)
4. Tettelin H, Masignani V, Cieslewicz MJ et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl Acad. Sci. USA 102(39), 13950-13955 (2005).
5. Maione D, Margarit I, Rinaudo CD et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309(5731), 148-150 (2005). (Pubitemid 40934997)
6. Nesvizhskii AI. Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol. Biol. 367, 87-119 (2007).
7. Pleissner KP, Eifert T, Buettner S et al. Web-accessible proteome databases for microbial research. Proteomics 4(5), 1305-1313 (2004). (Pubitemid 38648018)
8. Pleissner KP, Eifert T, Jungblut PR. A European pathogenic microorganism proteome database: construction and maintenance. Comp. Funct. Genomics 3(2), 97-100 (2002). (Pubitemid 34521188)
9. Zhang C, Crasta O, Cammer S et al. An emerging cyberinfrastructure for biodefense pathogen and pathogen-host data. Nucleic Acids Res. 36(Database issue), D884-D891 (2008). (Pubitemid 351149840)
10. Aebischer T, Schmitt A, Walduck AK, Meyer TF. Helicobacter pylori vaccine development: facing the challenge. Int. J. Med. Microbiol. 295(5), 343-353 (2005). (Pubitemid 41569402)
11. Bernardini G, Braconi D, Lusini P, Santucci A. Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev. Proteomics 4(5), 679-689 (2007). (Pubitemid 47623436)
12. Jagusztyn-Krynicka EK, Godlewska R. New approaches for Helicobacter vaccine development - difficulties and progress. Pol. J. Microbiol. 57(1), 3-9 (2008). (Pubitemid 351729688)
13. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 12(2), 89-102 (2007). (Pubitemid 46272562)
14. Bernardini G, Braconi D, Martelli P, Santucci A. Postgenomics of Neisseria meningitidis for vaccines development. Expert Rev. Proteomics 4(5), 667-677 (2007). (Pubitemid 47623435)
15. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 312(5771), 212-217 (2006).
16. Smith RD. Future directions for electrospray ionization for biological analysis using mass spectrometry. Biotechniques 41(2), 147-148 (2006). (Pubitemid 46542597)
17. Malmstrom J, Lee H, Aebersold R. Advances in proteomic workflows for systems biology. Curr. Opin. Biotechnol. 18(4), 378-384 (2007). (Pubitemid 47385185)
18. Doerr A. Focus on mass spectrometry in proteomics. Nat. Methods DOI:10.1038/nmeth1007-781 (2007) (Epub ahead of print). (Pubitemid 350055572)
19. Canas B, Lopez-Ferrer D, Ramos-Fernandez A, Camafeita E, Calvo E. Mass spectrometry technologies for proteomics. Brief. Funct. Genomic. Proteomic. 4(4), 295-320 (2006).
20. Gulcicek EE, Colangelo CM, McMurray W et al. Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies. Curr. Protoc. Bioinformatics Chapter 13, Unit 13.1 (2005).
21. Poetsch A, Wolters D. Bacterial membrane proteomics. Proteomics 8(19), 4100-4122 (2008). • Reviews various aspects of bacterial membranome studies presenting some technical achievements that allow the difficulties encountered during membrane protein extraction to be overcome.
22. Lu B, McClatchy DB, Kim JY, Yates JR 3rd. Strategies for shotgun identification of integral membrane proteins by tandem mass spectrometry. Proteomics 8(19), 3947-3955 (2008).
23. Tan S, Tan HT, Chung MC. Membrane proteins and membrane proteomics. Proteomics 8(19), 3924-3932 (2008).
24. Elia G. Biotinylation reagents for the study of cell surface proteins. Proteomics 8(19), 4012-4024 (2008).
25. Carr S, Aebersold R, Baldwin M et al. The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol. Cell. Proteomics 3(6), 531-533 (2004). (Pubitemid 38878512)
26. Whitelegge JP, Zabrouskov V, Halgand F et al. Protein-sequence polymorphisms and post-translational modifications in proteins from human saliva using top-down fourier-transform ion cyclotron resonance mass spectrometry. Int. J. Mass Spectrom. 268(2-3), 190-197 (2007).
27. Han X, Jin M, Breuker K, McLafferty FW. Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons. Science 314(5796), 109-112 (2006). (Pubitemid 44547751)
28. McAlister GC, Berggren WT, Griep-Raming J et al. A proteomics grade electron transfer dissociation-enabled hybrid linear ion trap-orbitrap mass spectrometer. J. Proteome Res. 7(8), 3127-3136 (2008).
29. Cargile BJ, Bundy JL, Freeman TW, Stephenson JL Jr. Gel based isoelectric focusing of peptides and the utility of isoelectric point in protein identification. J. Proteome Res. 3(1), 112-119 (2004). (Pubitemid 38233458)
30. Malmstrom J, Lee H, Nesvizhskii AI et al. Optimized peptide separation and identification for mass spectrometry based proteomics via free-flow electrophoresis. J. Proteome Res. 5(9), 2241-2249 (2006). (Pubitemid 44330817)
31. Herrero M, Ibanez E, Cifuentes A. Capillary electrophoresis-electrospray- mass spectrometry in peptide analysis and peptidomics. Electrophoresis 29(10), 2148-2160 (2008). (Pubitemid 351781211)
32. Ruotolo BT, Gillig KJ, Stone EG, Russell DH. Peak capacity of ion mobility mass spectrometry: separation of peptides in helium buffer gas. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 782(1-2), 385-392 (2002). (Pubitemid 35402040)
33. Motoyama A, Yates JR 3rd. Multidimensional LC separations in shotgun proteomics. Anal. Chem. 80(19), 7187-7193 (2008).
34. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 60(20), 2299-2301 (1988).
35. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 246(4926), 64-71 (1989). (Pubitemid 19252085)
36. Medzihradszky KF, Campbell JM, Baldwin MA et al. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal. Chem. 72(3), 552-558 (2000). (Pubitemid 33595291)
37. Jaskolla TW, Lehmann WD, Karas M. 4-chloro-a-cyanocinnamic acid is an advanced, rationally designed MALDI matrix. Proc. Natl Acad. Sci. USA 105(34), 12200-12205 (2008).
38. Bodnar WM, Blackburn RK, Krise JM, Moseley MA. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J. Am. Soc. Mass Spectrom. 14(9), 971-979 (2003). (Pubitemid 37040758)
39. Takats Z, Wiseman JM, Gologan B, Cooks RG. Electrosonic spray ionization. A gentle technique for generating folded proteins and protein complexes in the gas phase and for studying ion-molecule reactions at atmospheric pressure. Anal. Chem. 76(14), 4050-4058 (2004). (Pubitemid 38943677)
40. Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306(5695), 471-473 (2004). (Pubitemid 39372443)
41. Marshall AG, Hendrickson CL, Jackson GS. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom. Rev. 17(1), 1-35 (1998). (Pubitemid 128629493)
42. Scigelova M, Makarov A. Orbitrap mass analyzer - overview and applications in proteomics. Proteomics 6(Suppl. 2), 16-21 (2006). (Pubitemid 44625764)
43. Zubarev RA. Electron capture dissociation LC/MS/MS for bottom-up proteomics. Methods Mol. Biol. 492, 413-416 (2009).
44. Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad. Sci. USA 101(26), 9528-9533 (2004). (Pubitemid 38869270)
45. Crowe MC, Brodbelt JS. Infrared multiphoton dissociation (IRMPD) and collisionally activated dissociation of peptides in a quadrupole ion trap with selective IRMPD of phosphopeptides. J. Am. Soc. Mass Spectrom. 15(11), 1581-1592 (2004). (Pubitemid 39433852)
46. Good DM, Wirtala M, McAlister GC, Coon JJ. Performance characteristics of electron transfer dissociation mass spectrometry. Mol. Cell. Proteomics 6(11), 1942-1951 (2007). (Pubitemid 350213868)
47. Baldwin MA. Protein identification by mass spectrometry: issues to be considered. Mol. Cell. Proteomics 3(1), 1-9 (2004). (Pubitemid 38697101)
48. Fenyo D, Beavis RC. Informatics and data management in proteomics. Trends Biotechnol. 20(12 Suppl.), S35-S38 (2002).
49. Fenyo D. Identifying the proteome: software tools. Curr. Opin. Biotechnol. 11(4), 391-395 (2000). (Pubitemid 30598933)
50. Kapp E, Schutz F. Overview of tandem mass spectrometry (MS/MS) database search algorithms. Curr. Protoc. Protein Sci. Chapter 25, Unit 25.2 (2007).
51. Deutsch EW, Lam H, Aebersold R. Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics. Physiol. Genomics 33(1), 18-25 (2008).
52. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18), 3551-3567 (1999). (Pubitemid 30007252)
53. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acids in a protein database. J. Am. Soc. Mass Spectrom. 5(976), 976-989 (1994).
54. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4(3), 207-214 (2007). (Pubitemid 46358868)
55. Bradshaw RA, Burlingame AL, Carr S, Aebersold R. Reporting protein identification data: the next generation of guidelines. Mol. Cell. Proteomics 5(5), 787-788 (2006). (Pubitemid 43792788)
56. Taylor CF, Binz PA, Aebersold R et al. Guidelines for reporting the use of mass spectrometry in proteomics. Nat. Biotechnol. 26(8), 860-861 (2008).
57. Issaq H, Veenstra T. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives. Biotechniques 44(5), 697-698, 700 (2008). (Pubitemid 351656291)
58. Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1(5), 252-262 (2005).
59. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl Acad. Sci. USA 100(12), 6940-6945 (2003). (Pubitemid 36706372)
60. Chelius D, Bondarenko PV. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J. Proteome Res. 1(4), 317-323 (2002). (Pubitemid 36395872)
61. Pasa-Tolic L, Masselon C, Barry RC, Shen Y, Smith RD. Proteomic analyses using an accurate mass and time tag strategy. Biotechniques 37(4), 621-624, 626-633, 636 passim (2004). (Pubitemid 39391179)
62. Pan S, Aebersold R. Quantitative proteomics by stable isotope labeling and mass spectrometry. Methods Mol. Biol. 367, 209-218 (2007).
63. Gruhler S, Kratchmarova I. Stable isotope labeling by amino acids in cell culture (SILAC). Methods Mol. Biol. 424, 101-111 (2008).
64. 18O-labeled isotopic clusters. Mol. Cell. Proteomics 6(2), 305-318 (2007).
65. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17(10), 994-999 (1999). (Pubitemid 29474856)
66. Aggarwal K, Choe LH, Lee KH. Shotgun proteomics using the iTRAQ isobaric tags. Brief. Funct. Genomic. Proteomic. 5(2), 112-120 (2006). (Pubitemid 46403004)
67. Mueller LN, Brusniak MY, Mani DR, Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 7(1), 51-61 (2008). (Pubitemid 351171115)
68. Park SK, Venable JD, Xu T, Yates JR 3rd. A quantitative analysis software tool for mass spectrometry-based proteomics. Nat. Methods 5(4), 319-322 (2008).
69. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5(4), 573-588 (2006).
70. Falisse-Poirrier N, Ruelle V, ElMoualij B et al. Advances in immunoproteomics for serological characterization of microbial antigens. J. Microbiol. Methods 67(3), 593-596 (2006). (Pubitemid 44740201)
71. Bumann D, Jungblut PR, Meyer TF. Helicobacter pylori vaccine development based on combined subproteome analysis. Proteomics 4(10), 2843-2848 (2004). • Comparative and comprehensive analysis of Helicobacter pylori immunogens identified by numerous research groups that resulted in a list of 15 antigens - candidates for vaccine development.
72. Chitlaru T, Gat O, Grosfeld H, Inbar I, Gozlan Y, Shafferman A. Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome. Infect. Immun. 75(6), 2841-2852 (2007). (Pubitemid 46870165)
73. Bertone P, Snyder M. Advances in functional protein microarray technology. FEBS J. 272(21), 5400-5411 (2005). • Clear review highlighting the great potential of the protein microarray technology in basic and applied biology. (Pubitemid 41579404)
74. Eyles JE, Unal B, Hartley MG et al. Immunodominant Francisella tularensis antigens identified using proteome microarray. Crown Copyright 2007 Dstl. Proteomics 7(13), 2172-2183 (2007). (Pubitemid 47067203)
75. Hu S, Li Y, Liu G et al. A protein chip approach for high-throughput antigen identification and characterization. Proteomics 7(13), 2151-2161 (2007). (Pubitemid 47067201)
76. Glokler J, Angenendt P. Protein and antibody microarray technology. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 797(1-2), 229-240 (2003). (Pubitemid 37421308)
77. Wu HJ, Wang AH, Jennings MP. Discovery of virulence factors of pathogenic bacteria. Curr. Opin. Chem. Biol. 12(1), 93-101 (2008).
78. Xia Q, Hendrickson EL, Wang T, Lamont RJ, Leigh JA, Hackett M. Protein abundance ratios for global studies of prokaryotes. Proteomics 7(16), 2904-2919 (2007). • Presents recently developed technologies of quantitative proteomics, which allows precise comparison of protein quantity under different conditions. Combined with immunoproteomics, these strategies may reveal the shift of pathogen immunome during infection. (Pubitemid 47364660)
79. Giuliani MM, Adu-Bobie J, Comanducci M et al. A universal vaccine for serogroup B meningococcus. Proc. Natl Acad. Sci. USA 103(29), 10834-10839 (2006). (Pubitemid 44148381)
80. Malfertheiner P, Schultze V, Rosenkranz B et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a Phase I study. Gastroenterology 135(3), 787-795 (2008).
81. Mini R, Bernardini G, Salzano AM et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 833(1), 63-79 (2006).
82. Pheiffer C, Betts JC, Flynn HR, Lukey PT, van Helden P. Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology 151(Pt 4), 1139-1150 (2005). (Pubitemid 40568009)
83. Zhou M, Veenstra TD. Proteomic analysis of protein complexes. Proteomics 7(16), 2688-2697 (2007). (Pubitemid 47359914)
84. Lee SY, Jeoung D. The reverse proteomics for identification of tumor antigens. J. Microbiol. Biotechnol. 17(6), 879-890 (2007). (Pubitemid 47162050)
85. Matharoo-Ball B, Ball G, Rees R. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches - a prostate cancer perspective. Vaccine 25(Suppl. 2), B110-B121 (2007). (Pubitemid 47488553)
86. Simpson RJ, Bernhard OK, Greening DW, Moritz RL. Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Biol. 12(1), 72-77 (2008).
87. Sleno L, Emili A. Proteomic methods for drug target discovery. Curr. Opin. Chem. Biol. 12(1), 46-54 (2008).
88. de Souza GA, Malen H, Softeland T et al. High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics 9, 316 (2008).
89. Jungblut PR, Muller EC, Mattow J, Kaufmann SH. Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv not predicted by genomics. Infect. Immun. 69(9), 5905-5907 (2001). (Pubitemid 32786532)
90. Maillet I, Berndt P, Malo C et al. From the genome sequence to the proteome and back: evaluation of E. coli genome annotation with a 2-D gel-based proteomics approach. Proteomics 7(7), 1097-1106 (2007). (Pubitemid 46649158)
91. Rodriguez-Ortega MJ, Norais N, Bensi G et al. Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat. Biotechnol. 24(2), 191-197 (2006). (Pubitemid 43221703)
92. Ding XZ, Paulsen IT, Bhattacharjee AK, Nikolich MP, Myers G, Hoover DL. A high efficiency cloning and expression system for proteomic analysis. Proteomics 6(14), 4038-4046 (2006).
93. Guerrier L, D'Autreaux B, Atanassov C, Khoder G, Boschetti E. Evaluation of a standardized method of protein purification and identification after discovery by mass spectrometry. J. Proteomics 71(3), 368-378 (2008).
94. McCluskey AJ, Poon GM, Gariepy J. A rapid and universal tandem-purification strategy for recombinant proteins. Protein Sci. 16(12), 2726-2732 (2007). (Pubitemid 350172759)
95. Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287(5459), 1816-1820 (2000).
96. Backert S, Kwok T, Schmid M et al. Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5(5), 1331-1345 (2005). (Pubitemid 40503050)
97. Covert BA, Spencer JS, Orme IM, Belisle JT. The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis. Proteomics 1(4), 574-586 (2001). (Pubitemid 33588310)
98. Gat O, Grosfeld H, Ariel N et al. Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen. Infect. Immun. 74(7), 3987-4001 (2006). (Pubitemid 43993331)
99. Morsczeck C, Prokhorova T, Sigh J et al. Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin. Microbiol. Infect. 14(1), 74-81 (2008). (Pubitemid 350226574)
100. Bergmann S, Wild D, Diekmann O et al. Identification of a novel plasmin(ogen)-binding motif in surface displayed a-enolase of Streptococcus pneumoniae. Mol. Microbiol. 49(2), 411-423 (2003). (Pubitemid 36851197)
101. Xolalpa W, Vallecillo AJ, Lara M et al. Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis. Proteomics 7(18), 3332-3341 (2007). (Pubitemid 47517948)
102. Severin A, Nickbarg E, Wooters J et al. Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins. J. Bacteriol. 189(5), 1514-1522 (2007). • First study in which innovative method (trypsin digestion) was applied to release surface-exposed proteins for MS analysis. (Pubitemid 46446112)
103. Betts JC, Lukey PT, Robb LC, McAdamRA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43(3), 717-731 (2002). (Pubitemid 34597265)
104. Cho SH, Goodlett D, Franzblau S. ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis (Edinb.) 86(6), 445-460 (2006). (Pubitemid 44585233)
105. Florczyk MA, McCue LA, Stack RF, Hauer CR, McDonough KA. Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. Infect. Immun. 69(9), 5777-5785 (2001). (Pubitemid 32786517)
106. Mattow J, Siejak F, Hagens K et al. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 6(8), 2485-2494 (2006).
107. Starck J, Kallenius G, Marklund BI, Andersson DI, Akerlund T. Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 150(Pt 11), 3821-3829 (2004). (Pubitemid 39545327)
108. Seal BS, Hiett KL, Kuntz RL et al. Proteomic analyses of a robust versus a poor chicken gastrointestinal colonizing isolate of Campylobacter jejuni. J. Proteome Res. 6(12), 4582-4591 (2007).
109. Titball RW, Petrosino JF. Francisella tularensis genomics and proteomics. Ann. NY Acad. Sci. 1105, 98-121 (2007). (Pubitemid 47507096)
110. Chuang MH, Wu MS, Lin JT, Chiou SH. Proteomic analysis of proteins expressed by Helicobacter pylori under oxidative stress. Proteomics 5(15), 3895-3901 (2005).
111. Walz A, Mujer CV, Connolly JP et al. Bacillus anthracis secretome time course under host-simulated conditions and identification of immunogenic proteins. Proteome Sci. 5, 11 (2007). (Pubitemid 47308272)
112. Guina T, Wu M, Miller SI et al. Proteomic analysis of Pseudomonas aeruginosa grown under magnesium limitation. J. Am. Soc. Mass Spectrom. 14(7), 742-751 (2003). (Pubitemid 36870957)
113. Upritchard HG, Cordwell SJ, Lamont IL. Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins. Infect. Immun. 76(10), 4624-4632 (2008).
114. Manes NP, Gustin JK, Rue J et al. Targeted protein degradation by Salmonella under phagosome-mimicking culture conditions investigated using comparative peptidomics. Mol. Cell. Proteomics 6(4), 717-727 (2007). (Pubitemid 46630104)
115. Nanduri B, Shah P, Ramkumar M et al. Quantitative analysis of Streptococcus pneumoniae TIGR4 response to in vitro iron restriction by 2-D LC ESI MS/MS. Proteomics 8(10), 2104-2114 (2008). (Pubitemid 351775789)
116. Chaussee MA, Dmitriev AV, Callegari EA, Chaussee MS. Growth phase-associated changes in the transcriptome and proteome of Streptococcus pyogenes. Arch. Microbiol. 189(1), 27-41 (2008). (Pubitemid 350159673)
117. Choi YW, Park SA, Lee HW, Kim DS, Lee NG. Analysis of growth phase-dependent proteome profiles reveals differential regulation of mRNA and protein in Helicobacter pylori. Proteomics 8(13), 2665-2675 (2008).
118. Adkins JN, Mottaz HM, Norbeck AD et al. Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions. Mol. Cell. Proteomics 5(8), 1450-1461 (2006). (Pubitemid 44323298)
119. Shi L, Adkins JN, Coleman JR et al. Proteomic analysis of Salmonella enterica serovar typhimurium isolated from RAW 264.7 macrophages: identification of novel protein that contributes to the replication of serovar typhimurium inside macrophages. J. Biol. Chem. 281(39), 29131-29140 (2006). (Pubitemid 44507056)
120. Sriramulu DD, Nimtz M, Romling U. Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment. Proteomics 5(14), 3712-3721 (2005). (Pubitemid 41393303)
121. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3(4), 281-294 (2005). (Pubitemid 40443722)
122. Coiras M, Camafeita E, Lopez-Huertas MR, Calvo E, Lopez JA, Alcami J. Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents. Proteomics 8(4), 852-873 (2008). • Outstanding presentation of the impact of proteomics on understanding eukaryotic cell response to infection on proteome level. The knowledge of the host cell's response to pathogenic microorganisms is of great importance for the generation of new effective prophylactic and therapeutic strategies. (Pubitemid 351362939)
123. Backert S, Gressmann H, Kwok T et al. Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics 5(15), 3902-3918 (2005). (Pubitemid 41502487)
124. Chan CH, Ko CC, Chang JG et al. Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori. Mol. Cell. Proteomics 5(4), 702-713 (2006).
125. Galindo CL, Fadl AA, Sha J, Pillai L, Gutierrez C Jr, Chopra AK. Microarray and proteomics analyses of human intestinal epithelial cells treated with the Aeromonas hydrophila cytotoxic enterotoxin. Infect. Immun. 73(5), 2628-2643 (2005). (Pubitemid 40570328)
126. Ge Z, Zhu YL, Zhong X, Yu JK, Zheng S. Discovering differential protein expression caused by CagA-induced ERK pathway activation in AGS cells using the SELDI-ProteinChip platform. World J. Gastroenterol. 14(4), 554-562 (2008). (Pubitemid 351320821)
127. Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC. Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics 8, 91 (2007). • First work showing that the protein profiles of the cell lines routinely used in in vitro experiments are not identical to protein profiles of the cells present in the host tissues.
128. Khemiri A, Galland A, Vaudry D et al. Outer-membrane proteomic maps and surface-exposed proteins of Legionella pneumophila using cellular fractionation and fluorescent labelling. Anal. Bioanal. Chem. 390(7), 1861-1871 (2008).
129. Cordwell SJ, Len AC, Touma RG et al. Identification of membrane-associated proteins from Campylobacter jejuni strains using complementary proteomics technologies. Proteomics 8(1), 122-139 (2008).
130. Hooker BS, Bigelow DJ, Lin CT. Methods for mapping of interaction networks involving membrane proteins. Biochem. Biophys. Res. Commun. 363(3), 457-461 (2007). (Pubitemid 47513695)
131. Carlsohn E, Nystrom J, Karlsson H, Svennerholm AM, Nilsson CL. Characterization of the outer membrane protein profile from disease-related Helicobacter pylori isolates by subcellular fractionation and nano-LC FT-ICR MS analysis. J. Proteome Res. 5(11), 3197-3204 (2006). (Pubitemid 44749237)
132. Alteri CJ, Mobley HL. Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect. Immun. 75(6), 2679-2688 (2007). (Pubitemid 46870148)
133. Hagan EC, Mobley HL. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75(8), 3941-3949 (2007). (Pubitemid 47206292)
134. Kurupati P, Teh BK, Kumarasinghe G, Poh CL. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis. Proteomics 6(3), 836-844 (2006). (Pubitemid 43260209)
135. Peng X, Ye X, Wang S. Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 22(21-22), 2750-2756 (2004). (Pubitemid 38900650)
136. Ying T, Wang H, Li M et al. Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T. Proteomics 5(18), 4777-4793 (2005). (Pubitemid 43016899)
137. Ying TY, Wang JJ, Wang HL et al. Immunoproteomics of membrane proteins of Shigella flexneri 2a 2457T. World J. Gastroenterol. 11(43), 6880-6883 (2005).
138. Tjalsma H, Lambooy L, Hermans PW, Swinkels DW. Shedding & shaving: disclosure of proteomic expressions on a bacterial face. Proteomics 8(7), 1415-1428 (2008).
139. Mattow J, Siejak F, Hagens K et al. An improved strategy for selective and efficient enrichment of integral plasma membrane proteins of mycobacteria. Proteomics 7(10), 1687-1701 (2007). (Pubitemid 46841829)
140. Zheng J, Wei C, Leng W et al. Membrane subproteomic analysis of Mycobacterium bovis bacillus Calmette-Guerin. Proteomics 7(21), 3919-3931 (2007). (Pubitemid 350100008)
141. Malen H, Berven FS, Softeland T et al. Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics 8(9), 1859-1870 (2008). (Pubitemid 351678287)
142. Bumann D, Aksu S, Wendland M et al. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect. Immun. 70(7), 3396-3403 (2002). (Pubitemid 34665975)
143. Chaussee MA, McDowell EJ, Chaussee MS. Proteomic analysis of proteins secreted by Streptococcus pyogenes. Methods Mol. Biol. 431, 15-24 (2008).
144. Hathout Y. Approaches to the study of the cell secretome. Expert Rev. Proteomics 4(2), 239-248 (2007). (Pubitemid 46588459)
145. Lamonica JM, Wagner M, Eschenbrenner M et al. Comparative secretome analyses of three Bacillus anthracis strains with variant plasmid contents. Infect. Immun. 73(6), 3646-3658 (2005). (Pubitemid 40745909)
146. Malen H, Berven FS, Fladmark KE, Wiker HG. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7(10), 1702-1718 (2007). (Pubitemid 46841830)
147. Smith TG, Lim JM, Weinberg MV, Wells L, Hoover TR. Direct analysis of the extracellular proteome from two strains of Helicobacter pylori. Proteomics 7(13), 2240-2245 (2007). (Pubitemid 47067209)
148. Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19(22), 2645-2655 (2005). (Pubitemid 41627932)
149. Lee EY, Bang JY, Park GW et al. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7(17), 3143-3153 (2007).
150. Little SF. Anthrax vaccines: a development update. BioDrugs 19(4), 233-245 (2005). • Description of the work of several laboratory groups searching for alternative effective and well-tolerated vaccines against anthrax. (Pubitemid 41430158)
151. Galka F, Wai SN, Kusch H et al. Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect. Immun. 76(5), 1825-1836 (2008). (Pubitemid 351656116)
152. Ferrari G, Garaguso I, Adu-Bobie J et al. Outer membrane vesicles from group B Neisseria meningitidis d gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6(6), 1856-1866 (2006).
153. Vipond C, Suker J, Jones C, Tang C, Feavers IM, Wheeler JX. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics 6(11), 3400-3413 (2006). (Pubitemid 43886156)
154. Diaz-Mejia JJ, Babu M, Emili A. Computational and experimental approaches to chart the Escherichia coli cell-envelope-associated proteome and interactome. FEMS Microbiol. Rev. 33(1), 66-97 (2009).
155. Weiner JH, Li L. Proteome of the Escherichia coli envelope and technological challenges in membrane proteome analysis. Biochim. Biophys. Acta 1778(9), 1698-1713 (2008).
156. Grabenstein JD. Vaccines: countering anthrax: vaccines and immunoglobulins. Clin. Infect. Dis. 46(1), 129-136 (2008).
157. Leppla SH, Robbins JB, Schneerson R, Shiloach J. Development of an improved vaccine for anthrax. J. Clin. Invest. 110(2), 141-144 (2002). (Pubitemid 34787347)
158. Wang JY, Roehrl MH. Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin. Med. Immunol. 4(1), 4 (2005). (Pubitemid 41460812)
159. Read TD, Peterson SN, Tourasse N et al. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423(6935), 81-86 (2003). (Pubitemid 36569586)
160. Okinaka RT, Cloud K, Hampton O et al. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J. Bacteriol. 181(20), 6509-6515 (1999). (Pubitemid 29512963)
161. Pannucci J, Okinaka RT, Williams E, Sabin R, Ticknor LO, Kuske CR. DNA sequence conservation between the Bacillus anthracis pXO2 plasmid and genomic sequence from closely related bacteria. BMC Genomics 3(1), 34 (2002). (Pubitemid 39565252)
162. Ariel N, Zvi A, Grosfeld H et al. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect. Immun. 70(12), 6817-6827 (2002). (Pubitemid 35387914)
163. Ariel N, Zvi A, Makarova KS et al. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect. Immun. 71(8), 4563-4579 (2003). (Pubitemid 36919923)
164. Chitlaru T, Gat O, Gozlan Y, Ariel N, Shafferman A. Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activities. J. Bacteriol. 188(10), 3551-3571 (2006). (Pubitemid 43726220)
165. Brossier F, Levy M, Mock M. Anthrax spores make an essential contribution to vaccine efficacy. Infect. Immun. 70(2), 661-664 (2002). (Pubitemid 34083825)
166. Delvecchio VG, Connolly JP, Alefantis TG et al. Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Appl. Environ. Microbiol. 72(9), 6355-6363 (2006). (Pubitemid 44414669)
167. Kudva IT, Griffin RW, Garren JM, Calderwood SB, John M. Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect. Immun. 73(9), 5685-5696 (2005). (Pubitemid 41193004)
168. Destefano F, Pfeifer D, Nohynek H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bull. World Health Organ. 86(5), 373-380 (2008). (Pubitemid 351694318)
169. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol. Rec. 83(42), 373-384 (2008).
170. Cao J, Chen D, Xu W et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 25(27), 4996-5005 (2007). (Pubitemid 46879999)
171. Csordas FC, Perciani CT, Darrieux M et al. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide. Vaccine 26(23), 2925-2929 (2008).
172. Curtiss R 3rd, Zhang X, Wanda S et al. Induction of host immune response using Salmonella-vector vaccine. In: Virulence Mechanisms of Bacterial Pathogens. Teb KA (Ed.). ASM Press, Washington, DC, USA, 297-313 (2007).
173. Hamel J, Charland N, Pineau I et al. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect. Immun. 72(5), 2659-2670 (2004). (Pubitemid 38542392)
174. Kwon HY, Ogunniyi AD, Choi MH, Pyo SN, Rhee DK, Paton JC. The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infect. Immun. 72(10), 5646-5653 (2004). (Pubitemid 39303673)
175. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 75(1), 350-357 (2007). (Pubitemid 46047911)
176. Giefing C, Meinke AL, Hanner M et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205(1), 117-131 (2008). (Pubitemid 351185720)
177. Meinke A, Henics T, Hanner M, Minh DB, Nagy E. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine 23(17-18), 2035-2041 (2005). (Pubitemid 40341423)
178. Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front. Biosci. 8, s533-543 (2003).
179. Guilherme L, Fae KC, Higa F et al. Towards a vaccine against rheumatic fever. Clin. Dev. Immunol. 13(2-4), 125-132 (2006). (Pubitemid 44950031)
180. Musser JM, DeLeo FR. Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. Am. J. Pathol. 167(6), 1461-1472 (2005). (Pubitemid 41713301)
181. Moura H, Woolfitt AR, Carvalho MG et al. MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasive Streptococcus pyogenes isolates. FEMS Immunol. Med. Microbiol. 53(3), 333-342 (2008).
182. Batzloff MR, Pandey M, Olive C, Good MF. Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease. Immunol. Res. 35(3), 233-248 (2006). (Pubitemid 46020725)
183. Olive C. Progress in M-protein-based subunit vaccines to prevent rheumatic fever and rheumatic heart disease. Curr. Opin. Mol. Ther. 9(1), 25-34 (2007). (Pubitemid 46438446)
184. Shaila MS, Nayak R, Prakash SS et al. Comparative in silico analysis of two vaccine candidates for group A Streptococcus predicts that they both may have similar safety profiles. Vaccine 25(18), 3567-3573 (2007). (Pubitemid 46575098)
185. McMillan DJ, Batzloff MR, Browning CL et al. Identification and assessment of new vaccine candidates for group A streptococcal infections. Vaccine 22(21-22), 2783-2790 (2004). (Pubitemid 38900655)
186. Schmidt F, Schmid M, Thiede B, Pleissner KP, Bohme M, Jungblut PR. Assembling proteomics data as a prerequisite for the analysis of large scale experiments. Chem. Cent. J. 3(1), 2 (2009).
187. Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 124(4), 683-687 (2006). (Pubitemid 43261442)
188. Andersen P, Doherty TM. TB subunit vaccines - putting the pieces together. Microbes Infect. 7(5-6), 911-921 (2005). (Pubitemid 40826660)
189. Gayathri P, Balaram H, Murthy MR. Structural biology of plasmodial proteins. Curr. Opin. Struct. Biol. 17(6), 744-754 (2007). (Pubitemid 350180401)
190. McMurry J, Sbai H, Gennaro ML, Carter EJ, Martin W, De Groot AS. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes. Tuberculosis (Edinb) 85(1-2), 95-105 (2005). (Pubitemid 40431321)
191. Sable SB, Verma I, Khuller GK. Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. Vaccine 23(32), 4175-4184 (2005). (Pubitemid 40814593)
192. Vani J, Shaila MS, Chandra NR, Nayak R. A combined immuno-informatics and structure-based modeling approach for prediction of T cell epitopes of secretory proteins of Mycobacterium tuberculosis. Microbes Infect. 8(3), 738-746 (2006). (Pubitemid 44316502)
193. Livny J, Waldor MK. Identification of small RNAs in diverse bacterial species. Curr. Opin. Microbiol. 10(2), 96-101 (2007). (Pubitemid 46590045)
194. Romby P, Vandenesch F, Wagner EG. The role of RNAs in the regulation of virulence-gene expression. Curr. Opin. Microbiol. 9(2), 229-236 (2006).
195. Pichon C, Felden B. Proteins that interact with bacterial small RNA regulators. FEMS Microbiol. Rev. 31(5), 614-625 (2007). (Pubitemid 47246182)
196. Brennan RG, Link TM. Hfq structure, function and ligand binding. Curr. Opin. Microbiol. 10(2), 125-133 (2007). (Pubitemid 46590055)
197. Wilson JW, Ott CM, Honer zu Bentrup K et al. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc. Natl Acad. Sci. USA 104(41), 16299-16304 (2007). (Pubitemid 350099400)
198. J. Craig Venter Institute www.tigr.org/tigr-script/CMRHomePage.spl
199. GOLD: Genomes online database V. 2.0 www.genomesonline.org/
200. Drugs Information Online. Clinical trial results www.drugs.com/clinical- trials
201. Group A streptococcal vaccine development: current status and issues of relevance to less developed countries (WHO) www.who.int/child-adolescent-health/ documents/ivb-05-14/en/index.html
202. Stop TB Partnership and WHO. 2006. The Global Plan to Stop TB, 2006-2015, WHO/HTM/STB/2006.35 www.who.int/tb/publications/global-plan-to-stop-tb/en/ index.html0